416 related articles for article (PubMed ID: 33994512)
21. A new regimen for S-1 therapy aiming at adverse reaction mitigation and prolonged medication by introducing a 1-week drug-free interval after each 2-week dosing session: efficacy and feasibility in clinical practice.
Kimura Y; Kikkawa N; Iijima S; Kato T; Naoi Y; Hayashi T; Tanigawa T; Yamamoto H; Kurokawa E
Gastric Cancer; 2003; 6 Suppl 1():34-9. PubMed ID: 12775018
[TBL] [Abstract][Full Text] [Related]
22. Treatment of gastric cancer in Asia: the missing link.
Nishida T
Lancet Oncol; 2009 Nov; 10(11):1027-8. PubMed ID: 19880057
[No Abstract] [Full Text] [Related]
23. [A case of successful S-1 alternate-day administration for far-advanced remnant gastric cancer].
Kashima Y; Adachi T; Hara N; Sohtome I; Shirasaka T
Gan To Kagaku Ryoho; 2012 Mar; 39(3):469-72. PubMed ID: 22421782
[TBL] [Abstract][Full Text] [Related]
24. Combination chemotherapy of S-1 and low-dose cisplatin for advanced gastric cancer.
Tsujitani S; Fukuda K; Kaibara N
Gastric Cancer; 2003; 6 Suppl 1():50-7. PubMed ID: 12775021
[TBL] [Abstract][Full Text] [Related]
25. Feasibility study of S-1 for resectable gastric cancer with peritoneal seeding.
Fujitani K; Tsujinaka T; Hirao M
Hepatogastroenterology; 2003; 50(51):889-92. PubMed ID: 12828112
[TBL] [Abstract][Full Text] [Related]
26. Rapidly progressive glomerulonephritis caused by tegafur/gimeracil/oteracil resulted in diabetes nephropathy, in a patient with minor risk of diabetes nephropathy: a case report.
Toriu N; Sawa N; Imafuku A; Hasegawa E; Sekine A; Mizuno H; Yamanouchi M; Hiramatsu R; Hayami N; Hoshino J; Kawada M; Suwabe T; Ohashi K; Fujii T; Ubara Y
CEN Case Rep; 2020 Nov; 9(4):347-353. PubMed ID: 32378178
[TBL] [Abstract][Full Text] [Related]
27. Interstitial pneumonia possibly due to a novel anticancer drug, TS-1: first case report.
Kurakawa E; Kasuga I; Ishizuka S; Yoshida T; Kunisawa A; Minemura K; Utsumi K; Ohyashiki K
Jpn J Clin Oncol; 2001 Jun; 31(6):284-6. PubMed ID: 11463808
[TBL] [Abstract][Full Text] [Related]
28. A phase II study of S-1 in patients with metastatic breast cancer--a Japanese trial by the S-1 Cooperative Study Group, Breast Cancer Working Group.
Saek T; Takashima S; Sano M; Horikoshi N; Miura S; Shimizu S; Morimoto K; Kimura M; Aoyama H; Ota J; Noguchi S; Taguchi T
Breast Cancer; 2004; 11(2):194-202. PubMed ID: 15550867
[TBL] [Abstract][Full Text] [Related]
29. [A case of recurrent gastric cancer with dihydropyrimidine dehydrogenase (DPD) deficiency].
Hashimoto T; Arai K; Iwasaki Y; Saze Z; Takahashi K; Yamaguchi T; Matsumoto H; Yasutome M; Hiruma K; Yamashita Y
Gan To Kagaku Ryoho; 2006 Jul; 33(7):985-8. PubMed ID: 16835493
[TBL] [Abstract][Full Text] [Related]
30. [Feasibility of S-1/CDDP therapy for outpatients with advanced gastric cancer].
Rino Y; Murakami H; Yukawa N; Wada N; Oshima T; Matsuura H; Sugano N; Arai H; Masuda M; Imada T
Gan To Kagaku Ryoho; 2009 Nov; 36(11):1829-31. PubMed ID: 19920383
[TBL] [Abstract][Full Text] [Related]
31. Pathological Complete Response by S-1 Chemotherapy in Advanced Gastric Cancer.
Namikawa T; Ishida N; Tsuda S; Fujisawa K; Munekage E; Iwabu J; Munekage M; Uemura S; Tsujii S; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
In Vivo; 2018; 32(5):1211-1216. PubMed ID: 30150446
[TBL] [Abstract][Full Text] [Related]
32. [A Case of Gastric Cancer Underwent Two-Stage Gastrectomy after Chemotherapy-Induced Perforation].
Zen Y; Kaida S; Takebayashi K; Yamaguchi T; Murata S; Terada Y; Ueki T; Miyake T; Iida H; Akabori H; Kitamura N; Sonoda H; Shimizu T; Naka S; Tani M
Gan To Kagaku Ryoho; 2018 Feb; 45(2):377-379. PubMed ID: 29483453
[TBL] [Abstract][Full Text] [Related]
33. Spinal infarction related to the adjuvant chemotherapy for surgically resected non-small cell lung cancer: report of a case.
Matsutani N; Kawamura M
Jpn J Clin Oncol; 2013 May; 43(5):569-70. PubMed ID: 23487442
[TBL] [Abstract][Full Text] [Related]
34. Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients.
Sakata Y; Ohtsu A; Horikoshi N; Sugimachi K; Mitachi Y; Taguchi T
Eur J Cancer; 1998 Oct; 34(11):1715-20. PubMed ID: 9893658
[TBL] [Abstract][Full Text] [Related]
35. [A case of lethal interstitial pneumonia after neoadjuvant chemotherapy for advanced gastric cancer].
Kajihara K; Nagamatsu M; Takeoka Y; Kusaba T; Shigemasa Y; Hatano K; Sasaki N; Ikari H; Kunizaki T; Ooshima K; Yonemitsu N
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2310-2. PubMed ID: 24394095
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary toxicity by a cytotoxic agent, S-1.
Tada Y; Takiguchi Y; Fujikawa A; Kitamura A; Kurosu K; Hiroshima K; Sakao S; Kasahara Y; Tanabe N; Tatsumi K; Kuriyama T
Intern Med; 2007; 46(15):1243-6. PubMed ID: 17675777
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drug.
Hirata K; Horikoshi N; Aiba K; Okazaki M; Denno R; Sasaki K; Nakano Y; Ishizuka H; Yamada Y; Uno S; Taguchi T; Shirasaka T
Clin Cancer Res; 1999 Aug; 5(8):2000-5. PubMed ID: 10473078
[TBL] [Abstract][Full Text] [Related]
38. [Case report of a patient with advanced and disseminated gastric carcinoma treated by s-1].
Katolická J; Rotnáglová S; Vaníček J
Klin Onkol; 2014; 27(3):207-9. PubMed ID: 24918280
[TBL] [Abstract][Full Text] [Related]
39. [Successful treatment of gastric cancer accompanied by multiple liver metastases with TS-1 followed by curative gastrectomy affiliation].
Inoue S; Umekita N; Kitamura M
Gan To Kagaku Ryoho; 2002 Jun; 29(6):939-42. PubMed ID: 12090048
[TBL] [Abstract][Full Text] [Related]
40. Recurrence of nivolumab-induced Stevens-Johnson syndrome due to tegafur/gimeracil/oteracil (TS-1®) after nivolumab discontinuation.
Komatsu-Fujii T; Ogawa M; Nonoyama S; Fukumoto T; Tanabe H
Eur J Dermatol; 2021 Feb; 31(1):98-99. PubMed ID: 33586655
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
